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1. Introduction 
Peptic ulcers and gastritis are a serious and growing health problem in the whole world. 
Ulcers affect about 5 million Americans each year, and more than 40,000 people annually 
have ulcer-related surgery. Each year, approximately 15,000 people in the Unites States die 
of ulcer-related complications, the worst of which are an internal bleeding and perforation. 
A peptic ulcer is an open sore or lesion in the gastrointestinal mucosa (stomach or duodenum) 
that extends through the muscularis mucosa. Peptic ulcers occur when the mucous lining of 
the stomach or duodenum is not sufficient to protect them against the corrosive action of 
stomach hydrochloric acid, pepsin digestive enzyme, or against other aggressive substances. 
These aggressive factors can have an endogenous or exogenous origin. The endogenous 
harmful factors apart from hydrochloric acid and pepsin, are: refluxed bile, leukotrienes and 
Reactive Oxygen Species (ROS). The exogenous damaging factors include lifestyle factors, 
such as alcohol abuse, stress, tension and smoking; also, consume of steroidal and 
nonesteroidal anti-inflammatory drugs (NSAIDs) or drugs which stimulate gastric acid and 
pepsin secretion. Moreover, it is completely accepted that the bacterium called Helicobacter 
pylori (H. pylori) is implicated in the development of gastric ulcers and gastritis.  
However, many researchers suggest that both the presence of H. pylori and the 
circumstances related to lifestyle and the consumption of certain drugs are risk factors to 
develop ulcer, but not the underlying causes, consequently, they add severity to the 
problem but are not able to cause it. Although these factors are almost certainly of 
pathogenic relevance, there are majority of people with exposure to them who remain ulcer-
free and only a small number of them develop ulcers. In fact, considering the acid-peptic 
environment of the stomach, the noxious agents both the endogenous and the exogenous 
that are ingested, and the high prevalence of H. pylori infection, ulcers are surprisingly 
uncommon. 
To explain this, it is thought that in gastric mucosa is established a balance between these 
aggressive factors and other cytoprotective factors, and that gastric ulcer appears when the 
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balance is lost. The mucosal defense is constituted by mucus-bicarbonate barrier, surface 
active phospholipid, prostaglandin, mucosal blood flow, cell renewal and migration, 
antioxidants and antioxidant enzymes, and some growth factors.  
2. Free radicals and antioxidant defences 
Gastroduodenal disease is associated with a variety of risk factors, including tobacco smoke, 
hereditary influences, sex, diet, stress and the actions of drugs (NSAIDs) (Marotta & Floch, 
1991; Wallace, 1992). There is evidence that free radicals and antioxidants may be important 
components in the pathophysiology of gastroduodenal disease caused by many of these 
factors, implicating H. pylori. Free radicals have been involved in a wide spectrum of human 
diseases including other digestive disorders such as inflammatory bowel, toxic liver injury 
or pancreatic disease (Phull et al., 1995). 
ROS can be defined as any chemical species capable of independent existence that contain 
one or more unpaired electrons in their outer orbital. Considering that the most stable 
molecular species have the electrons within their outer orbital arranged in pairs, free 
radicals tend to be unstable and highly reactive. 
Oxygen is the most abundant radical in biological systems. The seemingly paradoxical 
consequences of the beneficial and harmful effects of oxygen (O2) have been shown for 
several decades. While more than 95% of the O2 consumed by the aerobic organisms is fully 
reduced to water during the process of mitochondrial respiration, a small percentage (<5%) 
is converted to semireduced species such as superoxide anion radical (O2.-), hydrogen 
peroxide (H2O2) and hydroxyl radical (OH.). These species are collectively named “Reactive 
Oxygen Species or ROS”. ROS are formed continuously as normal byproducts of cellular 
metabolism and several of their sources are mitochondrial oxidative phosphorylation, 
prostaglandin synthesis, non-mitochondrial respiratory burst of neutrophils, and possibly 
the inhibition of mitochondrial electron transport. 
Antioxidant defences: Free radicals play a number of physiological roles, but due to their 
high reactivity tend to attack the first biochemical component that they encounter inside 
cells, including macromolecules such as lipids, proteins or nucleic acids and bring about 
oxidative damage (Reilly et al., 1991). To avoid the oxidative damage, cells have 
development defence mechanisms to limit or prevent the toxicity caused by an excessive 
ROS activity. These defenses include non-enzymatic compounds such as vitamin (Vit) A, E 
and C, and enzymatic substances such as superoxide dismutase, catalase, glutathione 
peroxidase, and glutathione S-transferase; the latter two enzymes using glutathione (GSH) 
as a cofactor. Tissue damage may result from excessive ROS activity, from any deficiency in 
the defence mechanisms or from both of them.  
It is well known that low/moderate concentrations of ROS affect a great number of 
physiological functions. However, when ROS concentration exceeds the antioxidative 
capacity of an organism, cells enter a state termed oxidative stress, in which the excess 
ROS induces oxidative damage on cellular components. So, ROS have been implicated in 
the pathogenesis of many human sufferings like Parkinson’s, Alzheimer, Huntington’s 
diseases and many other neurodegenerative conditions (Halliwell B, 1989). There is ample 
evidence that free radicals and antioxidants may be important components in the 
pathophysiology of gastroduodenal disease, in fact, as noted above, an exacerbated 
synthesis of free radicals has been implicated in inflammatory bowel disease, toxic liver 
injury or pancreatic disorders. 
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3. Free radicals, antioxidant defences and gastroduodenal diseases 
A growing body of experimental and clinical evidence suggests that gastric mucosal damage 
by ethanol, NSAIDs and by H. pylori (Davies et al., 1994) is mediated through ROS (Phull et 
al., 1995). The cause could be the excessive synthesis, the deficiency of antioxidants defences 
or the coexistence of both reasons.  
Most of the studies in this area have focused on the link between low intakes of fresh fruit 
and/or vegetables and gastric cancer. Several data show that exist an increased risk of 
gastric cancer specifically related to low intakes of Vit C and -carotene or that -carotene 
and Vit E levels were significantly lower in subjects with gastric dysplasia, a precursor of 
gastric cancer (Haenszel et al., 1985). Lower plasma levels of Vit A, C and E in subjects with 
chronic atrophic gastritis (Jaskiewicz et al., 1990) has been detected in a cross-sectional and 
prospectives studies showing that an increased risk of gastric cancer is associated with low 
plasma -tocoferol (Knekt et al., 1991), Vit C, -carotene (Stahelin et al., 1991), retinal levels 
and with low selenium levels (van den Brandt et al., 1993). Respect to the selenium, some 
evidence suggest that the diet of dyspeptic patients is deficient in the micronutrient 
selenium, which is an important constituent of the antioxidant enzyme glutathione 
peroxidase (GSH-Px). 
Involvement of ROS in the pathogenesis of gastric ulceration was first evident from the 
studies of ischemia-reoxygenation-induced gastric mucosal injury. Many of the works in 
this area have been performed by Davies et al using a chemiluminiscence assay (Davies et 
al., 1994). They have shown significantly greater free radical production in duodenal 
mucosal biopsies from patients with duodenal ulceration and severe duodenitis that in 
patients with mild duodenitis or controls. This increased free radical activity in duodenal 
ulcer patients is accompanied by reduced levels of plasma glutathione (GSH). Recent studies 
show the same conclusions: there is an increased ROS production in gastric ulceration 
compared with gastric antral mucosa (Peng et al., 2008). Gastric ulceration also appears to be 
associated with increased plasma free radical activity and lower levels of Vit C and E, but 
not with superoxide dismutase (SOD) or catalase. ROS also decrease the level of 
endogenous antioxidants such as GSH, -tocopherol and ascorbate, and make the mucosa 
more prone to oxidative damage.  
Moreover, ROS may play an important role in gastric ulceration induced by several kinds of 
stress. The pathogenesis of gastric mucosal lesions by water immersion restraint stress and 
burn shock in rat is associated with increased lipid peroxidation. Furthermore, cold restraint 
stress has been shown to alter the level of various damaging and cytoprotective factors of rat 
gastric mucosa to cause gastric ulceration (Das et al., 1997). It was reported (Yoshikawa et 
al., 1989) that the gastric mucosal injury induced by ischemia-reperfusion is avoided after 
administration of SOD and catalase, indicating the role of lipid peroxidation and ROS in the 
origin of the lesion. Similarly, astaxanthin has been shown to provide protection against 
naproxen-induced and stress-induced gastric ulceration by reducing the level of lipid 
peroxides and free radicals indicating again the role of ROS in gastric damage (Oh et al., 
2005). The inhibitory effect of diacerein on indomethacin-induced gastric ulceration by 
inhibition of neutrophil activation (Tamura et al., 2001), and consequently the suppression 
of ROS production by these cells, leads to similar conclusions.  
Furthermore, Davies et al. (Davies et al., 1994) also detected higher levels of ROS in antral 
mucosa infected with H. pylori and they affirmed that there is no evidence for ROS 
participation in gastric mucosal injury in cases not related to H. pylori infection. Other works 
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show that ROS levels are directly correlated with the infective load of H. pylori (Zhang et al., 
2007) and lipid peroxidation has been also shown to be increased in H. pylori-positive gastric 
mucosa. 
But although it has been established a clear association between bacteria infection and 
impaired synthesis of ROS, many other clinical data suggest that other factors inherent to 
host conditions (stress, diet, tobacco, hygiene, genetics...) contribute to the pathogenesis of 
this infection (Oh et al., 2005). It should be noted that some of these factors, including 
ingested food and tobacco smoke, directly influence in mucosal oxidative status, since they 
expose the gastric epithelium to the ROS that they generate within the gastric lumen in a 
sustained manner. 
4. Helicobacter pylori and gastroduodenal diseases 
4.1 Short history 
The evolution over time of the peptic ulcer epidemiology reflects a complex and 
multifactorial etiology. Peptic ulcers were rare before 1800, so the gastric ulcer pathology 
was not described until 1835 (J. 1835 Cruveilhier maladies de l'estomac In Anatomy of 
Human Bailliere Pathologique du Corps, Paris ...). During the nineteenth century, the 
predominant form was gastric ulcer in young women, while duodenal ulcer was rare until 
the twentieth century. However, duodenal ulcer was gradually more prevalent until become 
the more frequent condition in the middle of the century. Moreover, in developed countries 
the mortality from peptic ulcer has been drastically reduced for the cohorts born after the 
start of the twentieth century (Sonnenberg, 2007). 
It is now clear that the epidemiology of the peptic ulcer is mainly due to external 
environmental factors, among which are include H. pylori infection, the use of NSAIDs and 
smoking. However, these factors do not explain the whole story of the evolution in time and 
the birth-cohort effect for peptic ulcer. Specifically, H. pylori was a prevalent human 
infection before 1800, so that infection per se cannot explain the increased prevalence of the 
ulcer after this time nor the shift from gastric ulcer to duodenal ulcer (Graham, 2003). 
Interest in understanding the role of H. pylori in gastroduodenal diseases was started in the 
1970s with the visualization of bacteria in the stomach of gastric ulcer patients, although the 
more important researches about it were carry out by the Australian pathologist Berry 
Marshal in 1979 in collaboration with J Robin Warren from 1981 (Warren JR, 1983). Almost 
by accident, successful culture of H. pylori in 1982 occurred. Marshall frustrated by not being 
able to get a good animal model of infection, ingested these bacteria and he became ill, 
developed inflammation and ulcer of stomach, and he was able to culture the bacteria from 
his own ulcer, proving H. pylori to be the cause of ulcers. They published the results of self-
induced infection in 1985 (Marshall et al., 1985) and initially, the isolated bacteria was 
termed Campylobacter pyloridis but it was re-named Helicobacter pylori (H. pylori) when 
biochemical and genetic characterization of the organism showed that it was not a member 
of the Campylobacter genus (Tan & Wong, 2011). 
4.2 Morphological and biochemical characteristics  
H. pylori is a spiral-shaped, flagellated, microaerophilic Gram-negative bacillus. It inhabits 
various areas of stomach and duodenum. Stomach is normally a hostile environment to the 
survival of viruses, bacteria and other micro-organisms due to its low pH. However H. 
pylori has evolved to be uniquely suited to thrive in the harsh stomach environment (Fig. 1). 
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The bacterium secretes urease, a special enzyme that converts urea to ammonia. Ammonia 
reduces the acidity of stomach, making it more hospitable home for H. pylori (Pandey et al., 
2010). 
 
 
Fig. 1. H. pylori localization in the gastric mucosa and ammonia production. 
H. pylori exerts a trophic influence on the gastric epithelium, but before it can attach to the 
epithelium surface it has first to cross the thick mucus layer by adhering to the mucosal 
surface. The presence of unipolar flagella helps to establish the H.pylori colonization of the 
stomach and its attachment to the epithelial surface of mucosa in the stomach despite the 
host attempts to rid itself of the bacterial infection. It is of interest that mutant H. pylori 
strains that are non-motile are unable to colonize the stomach of gnotobiotic piglets (Eaton 
et al., 1989). 
4.3 Time, mode and geographic distribution of infection 
H. pylori colonizes the gastric mucosa of more than 50% of human population. Infection is 
usually acquired in childhood while natural acquisition in adults is rare. The major risk 
factor for H. pylori infection are the socio-sanitary conditions lived during childhood, 
particularly at home, being important factors the level of sanitation, hygiene, and number of 
people in the household (the overcrowding). Studies in Kazakhstan (Nurgalieva et al., 2002) 
and Peru (Klein et al., 1991), have confirmed that high H. pylori infection prevalence in 
children in these countries, is related to these factors besides with the use of contaminated 
water with bacteria. These data determine that the water could be a reservoir and a 
transmission route for the bacteria. 
Moreover, although it has been demonstrated a family association for infection (Nam et al., 
2011), the transmission mode of H. pylori between individuals and within families remains 
to be elucidated and several interesting myths related to oral-oral transmission have been 
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debunked when a study of couples without children revealed a low concordance of H.pylori 
infection (Perez-Perez et al., 1991); currently favored mechanisms of transmission appear to 
be gastro-oral and faecal-oral routes (Xia & Talley, 1997). Genetic susceptibility also appears 
to be significant in the acquisition of H.pylori infection as well as its clearance (Malaty et al., 
1994). 
 
 
Fig. 2. H. pylori world distribution 
Although generally speaking a rate of infection worldwide by about 50%, prevalences 
varying widely within countries (Fig. 2), and even between geographical areas of the same 
country (Krejs, 2010). Thus, in developing countries such as the eastern regions of Asia and 
in some parts of Latin America, the infection prevalence is characterized by a rapid rate of 
acquisition, usually in childhood, so that about 80% of the population is infected by the age 
of 20 (Graham et al., 1991).  
In contrast, in developed countries such as Spain, USA, UK or Australia, the prevalence of 
H. pylori infection in children is low for ages below 10 years, and peaks of 40% aproximately, 
occur about to 30-40 years of age (Lehours & Yilmaz, 2007). 
4.4 General features of Helicobacter pylori infection 
In all infected subjects by H. pylori, the basic process that mediates the mucosa damage is the 
development of gastritis, whose extent and distribution will determine the clinical outcome 
(Amieva & El-Omar, 2008).  
The arrival of lymphocytes and plasma cells in the mucosa signals augmentation of the 
acute inflammatory response by the production of cytokines and specific anti-H. pylori 
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Fig. 3. H. pylori, gastritis and disease. During infection with H. pylori a number of 
inflammation patterns are associated with different disease stages. 
antibodies. However, this vigorous response fails to eliminate infection, and the continued 
presence of H. pylori leads to the development of a second arm of the immune response 
more specifically aimed at preventing the damaging effects of intraluminal pathogens. 
The initial acute phase of infection is subclinical in the great majority of subjects. This phase 
is short lived, and histologically results in a neutrophilic gastritis followed by a gradual 
infiltration of the gastric mucosa by inflammatory cells, and is coupled with a transient 
hypochlorhydria (Egan et al., 2007).  
In a small minority of people, and particularly in childhood, the bacteria may be 
spontaneously cleared, the cellular infiltrate resolves, and the mucosa return to normal 
appearance. However, in the majority of subjects although H. pylori stimulates a robust 
inflammatory and immune response, the host fails to eliminate the infection and over the 
next 3 or 4 weeks there is a gradual accumulation of chronic inflammatory cells that come to 
dominate the histological picture. An acute neutrophilic gastritis gives way to an active 
chronic gastritis or “bening gastritis” characterized by mild pangastritis with little 
disruption of gastric acid secretion. This phenotype is exhibited by the asymptomatic 
subjects and those who do not develop serious gastrointestinal alterations (Amieva & El-
Omar, 2008). In fact, it is commonly accepted that H. pylori infection, followed by the 
induction of inflammatory changes in gastric mucosa, may persist for decades without 
causing any gastric disturbances (Konturek et al., 2009). 
Chronic gastritis is a common denominator linking peptic ulceration, gastric carcinoma, and 
lymphoma, and the histological picture encompassed chronic inflammation, atrophy, and 
intestinal metaplasia and finally adenocarcinoma (Dixon, 2001) (Fig. 3). Once chronic 
gastritis is established, it can progress mainly towards two topographic patterns that are 
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related to different clinical outcomes. The first pattern named “duodenal ulcer” phenotype 
is an antral predominant gastritis, accounts for up 15% of infected subjects and is 
characterized by inflammation mostly limited to the antrum. Subjects with this phenotype 
have high antral inflammatory scores, high gastrin, relatively healthy corpus mucosa, and 
very high acid output (Graham & Yamaoka, 1998). These subjects also have defective 
inhibitory control of gastric acid secretion.  
This combination of pathophysiologic abnormalities contributes to the development of 
peptic ulcers, and confers protection against gastric cancer. Conversely, gastric ulcers are 
thought to be initially associated with a chronic non-atrophic gastritis which progresses to 
chronic atrophic gastritis involving both corpus and, invariably, the antrum and decreased 
acid output.  
The second pattern, termed “gastric cancer” phenotype, is one of progressive pan-gastritis 
or multifocal atrophic gastritis, and hypo- or achlorhydria, characterized by active infection 
of both the gastric corpus and antrum with progressive development of gastric atrophy and 
intestinal metaplasia. These abnormalities affect at 1% of H. pylori-infected individuals who 
presented an increased risk of development gastric carcinoma (Amieva & El-Omar, 2008).  
It is clear that H. pylori infection can lead to several divergent clinical outcomes. Explaining 
this apparent paradox is essential for understanding the pathogenesis of H. pylori-related 
disease because the mechanisms underlying the differences in outcome of H. pylori infection 
are currently poorly understood. It appears that the host reaction to the infection is very 
complex and it has been hypothesized that many sequential events and several mechanisms 
of tissue injury participate in the process. Between these pathogenic mechanisms of H. pylori 
are identified the induction of gastric inflammation, the disruption of the gastric mucosal 
barrier and the altered gastrin-gastric acid homeostasis (Dunn et al., 1997). Also, these 
different clinical manifestations of the infection are influenced by the host characteristics, the 
environmental factors and the bacterial genetic. Host factors are mainly related to the 
recognition of H. pylori by the immune system, variations in the level of cytokine response, 
sex and hereditary influences. Environmental data include tobacco smoke, diet, stress and 
the action of drugs such as NSAIDs. Bacterial factors may increase the risk of more severe 
disease, causing increased proinflammatory cytokine release. Strains possessing the “cag 
pathogenicity island” are more likely to be associated with peptic ulceration or gastric 
adenocarcinoma than strains lacking it. Another genes and proteins, such as iceA, vacA, 
OipA, BabA, have been analyzed but different studies were unable to show an association 
between them and the pattern of gastritis (Egan et al., 2007). 
4.5 Toxicity of Helicobacter pylori on gastric mucosa (ROS) 
In the early stages of infection, H. pylori induces secretion of chemokines (RANTES, GRO, 
MIP-1, ENA-78, MCP-1, and IL-8), as well as of proinflammatory cytokines (IL-1, IL-6 and 
TNF-, mainly) (Ibraghimov & Pappo, 2000). These molecules provoke recruitment of cells 
(macrophages, PMN, mast cells, T and B lymphocytes) to the infected gastric tissue, being 
neutrophils the initial inflammatory component of the response to the pathogen (Naito & 
Yoshikawa, 2002). Recruited PMNs, in turn, secrete more inflammatory mediators that 
amplify the primary signal and mediates directly the influx of more PMN to the gastric 
mucosa. Furthermore, soluble proteins of H. pylori can also function as chemoattractants for 
neutrophils. PMNs into gastric tissue induce oxidative burst responses in phagocytes being 
these activities typical in the development of gastric disease. It is demonstrated that H. pylori 
www.intechopen.com
 
Helicobacter pylori and Peptic Ulcer – Role of Reactive Oxygen Species and Apoptosis 
 
173 
isolates which induce a strong and rapid oxidative burst in neutrophils are associated with 
higher inflammation scores in gastric ulcer patients and with histological mucosal damage 
(Louw et al., 1993). Furthermore, IL-8 levels secreted by mucosa cells positively correlate 
with infiltration of PMN and mononuclear cells, and with higher production of ROS in H. 
pylori-infected antral gastric mucosa (Danese et al., 2001). 
ROS production in H. pylori infection is catalyzed by nicotinamide adenine dinucleotide 
phosphate oxidase (NADPH oxidase; Nox) on the cell membrane (Lambeth, 2004). It is also 
produced superoxide anion (O2˙-), a precursor of microbicidal oxidants. This O2˙- is 
converted to hydrogen peroxide (H2O2) by superoxide dismutase (SOD) catalysis, or by non-
enzymatic dismutation in the phagosome. H2O2 can passively permeate cell membranes and 
is converted to hypochlorous acid (HOCl), which is 100 times more toxic than H2O2. This 
conversion is mediated by myeloperoxidases (MPO) released by Azur granules in 
phagocytes in the presence of chloride ions (Cl-). H2O2 also reacts nonenzymatically with 
O2˙- to form hydroxyl radicals (˙OH) in the presence of ferrous (Fe2+) or cuprous (Cu+) ions. 
In general, these highly reactive ROS (i.e., HOCl and ˙OH) are used by the phagocyte to kill 
pathogenic bacteria (Fig.4).  
However, in H. pylori-infected gastric mucosa, these ROS cannot eradicate H. pylori and this 
excessive production is believed to be a major cause of gastric mucosal damage, inducing 
oxidative stress to the gastric mucosa cells (Handa et al., 2010). 
Thus, the role of oxidative stress on gastric mucosa is multi-functional. For neutrophils, it is 
the result of excessive defense reactions of the body against H. pylori intrusion, and for H. 
pylori, it is a convenient tool for invading the human gastric mucosa. 
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Fig. 4. Sources of ROS and the detoxification systems in H. pylori 
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As noted above, some factors that may further aggravate the pathogenicity caused by H. 
pylori are the genetic characteristics of bacteria. In fact, the possession of "cytotoxin-
associated gene (cagA) or pathogenicity island" is associated with a high prevalence of 
peptic ulcer disease. And also, according to the authors Danese et al (Danese et al., 2001) and 
others, the gastric mucosa of patients infected by CagA (+) strains are characterized by 
increased ROS generation and neutrophil counts greater than that observed in CagA (-) 
subjects. 
4.6 Helicobacter pylori, ROS and cellular apoptosis 
Several studies have shown a relationship between H. pylori infection and an increased 
apoptosis rate in gastric lesions such as chronic gastritis, generally accompanied by 
glandular atrophy, gastric ulcer and intestinal metaplasia. Specifically, studies in patients 
with gastric ulcer determine a higher apoptotic index in this type of gastric lesion with H. 
pylori infection compared to H. pylori-negative normal gastric mucosa (Targa et al., 2007). 
Results of Satoh et al (Satoh et al., 2003) showed that apoptosis, not only of surface epithelial 
cells but also of glandular cells in the upper portion of fundic glands, is increased in H. 
pylori-positive patients with gastric ulcers and decreased to normal levels after eradication 
of H. pylori. Recent studies are intended to avoid triggering apoptotic processes caused by H. 
pylori (Hsu et al., 2010). In these experiments, authors use substances capable of inhibiting 
the activation of caspase cascade (extract solanum lyratum in this study). This could be a 
new approach for the treatment of infection with H. pylori. 
It is known that some of the major stimuli that can induce apoptosis are: ionising radiation, 
viral infection, growth factor depletion, cytoplasmic stress, serum starvation, presence of 
hormones such as corticosteroids, the damage to genetic material and an excessive presence 
of free radical. Given that one of the factors that triggers cellular apoptosis is the excess of 
ROS, it is reasonable to think that the apoptosis observed in gastric mucosal cells infected by 
H. pylori may have this origin.  
Apoptosis was first described in 1972 by Currie and colleagues (Kerr et al., 1972). It plays a 
pivotal part in many physiological settings, including the embryonic and post-embryonic 
development of multicellular organisms, tissue homeostasis and the removal of damaged 
and/or infected cells. It is delicately regulated and balanced in a physiological context. 
Failure of this regulation results in pathological conditions such as developmental defects, 
autoimmune diseases, neurodegeneration or cancer (Thompson, 1995). Apoptosis is by far 
the best-characterized mode of programmed cell death that is associated to morphological 
features that had been repeatedly observed in various tissues and cell types. Apoptotic cells 
display typical morphological features such as nuclear fragmentation, chromatin 
condensation and cell shrinkage, and eventually break down into apoptotic bodies. These 
morphological changes are accompanied by ATP-dependent biochemical changes that lead 
to the cells to various functional alterations. The results of these changes are reflected in an 
asymmetry of the cytoplasmic membranes by translocation of phosphatidylserine to the 
surface, breaking of DNA in multiples fragments (ladder pattern), release of pro-apoptotic 
proteins (cytochrome c (cyt c), AIF,…) from the mitochondria to cytosol, activation of 
caspases cascade, and finally, cell death.  
Apoptotic cascade appears to have many regulatory “switch points’’ between proapoptotic 
and antiapoptotic forces. The imbalance of these forces has led to several key concepts 
regarding the importance of apoptosis in health and disease. Thus, atrophy of an organ with 
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a decrease in cell numbers could be related to an increase in cellular apoptosis, whereas 
tissue proliferation may be associated with molecular inhibition of apoptosis; in some 
diseases, internal or external factors could trigger the proapoptotic machinery within the cell 
causing cell death and tissue destruction; or cellular malignant transformation may occur 
because of a failure to activate apoptosis and delete cells with genetic damage (i.e., 
oncogenic mutations). These concepts suggest the possibility that several treatment 
strategies are useful in certain clinical conditions. Thus, inhibition of apoptosis could 
facilitate tissue repair processes by promoting cellular proliferation, and tissue regeneration, 
and, moreover, induction of apoptosis could be proven useful in treating malignant 
carcinomas (Que & Gores, 1996). 
In relationship with the gastrointestinal tract, apoptosis plays an important role in the 
regulation of epithelial cell numbers, being the deregulation of the apoptotic pathway 
implicated in a number of disease processes in the gastrointestine. In H. pylori-induced 
chronic gastritis, cell loss by apoptosis is excessive compared with proliferation, suggesting 
that infection with the bacteria triggers the acceleration of apoptosis, fact that has been 
proven in in vivo experiments (Hall et al., 1994). 
Two distinct, but partially overlapping, pathways are known to lead to apoptosis (Fig.5):  
- the extrinsic (receptor mediated pathway), and  
- the intrinsic (mitochondrial pathway). 
The extrinsic pathway is activated by apoptotic stimuli comprising external signals such as 
the binding of death inducing ligands to cell surface receptors. Among death inducing 
ligands more studied are Fas, tumor necrosis factor receptor or TRAIL receptors.  
Death ligand stimulation results in oligomerization of the receptors and recruitment of the 
adaptor protein Fas-associated death domain (FADD) and caspase-8, forming a death-
inducing signalling complex (DISC). Autoactivation of caspase-8 at the DISC is followed by 
activation of effector caspases, including caspase-3, -6 and -7, which function as downstream 
effectors of the cell death program (Ashkenazi & Dixit, 1998). Fas has a central role in the 
physiological regulation of apoptosis and has been implicated in the pathogenesis of various 
malignancies as well as in diseases of the immune system. Fas is involved in cytotoxic T-cell 
mediated killing of cells (for example, CTL-mediated killing of virus-infected cells), 
destruction of inflammatory and immune cells in immune-privileged sites, deletion of self-
reacting B cells and activated T-cells at the end of an immune response (Jin & El-Deiry, 2005).  
Some in vitro studies reveal that H. pylori stimulates apoptosis of gastric epithelial cells in 
association with the enhanced expression of the Fas receptor, indicating a role for Fas-
mediated signaling in the programmed cell death that occurs in response to H. pylori 
infection (Jones et al., 1999). Wang et al. (Wang et al., 2000) also demonstrated that local Th1 
cells (cellular subtype that is mainly recruited to the gastric mucosa during the infection) 
may contribute to the pathogenesis of gastric disease during H. pylori infection by increasing 
the expression of Fas on gastric epithelial cells and inducing apoptosis through Fas/FasL 
interactions. Moreover, H. pylori can sensitize human gastric epithelial cells and enhance 
susceptibility to TRAIL-mediated apoptosis (Wu et al., 2004). 
Intrinsic apoptotic pathway is initiated inside cells. The most important turning point in the 
course of the intrinsic apoptotic process occurs in the mitochondria. Their structure and 
compartmentalization are highly related to a perfect performance of their functions, being 
the most relevant, in eukaryotic cells, energy production in ATP form molecules (Chinnery 
& Schon, 2003).  
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Fig. 5. Apoptotic pathways: the extrinsic pathway involves so-called death receptors, the 
intrinsic one involves mitochondrial alterations. Both pathways converge at caspase-3 
activation, where classic biochemical and morphological changes in association with the 
apoptotic phenotype are originated 
Every mitochondrion has a double lipid envelope that delimites the matrix, located within the 
inner mitochondrial membrane (IMM) and the intermembrane space located, in turn, between 
the IMM and the outer mitochondrial membrane (OMM). IMM cristae or invaginations 
increase the area where specific mitochondrial processes develop (electron transport and 
oxidative phosphorylation) (Fig. 6). The efficacy of these processes greatly depends on the 
bilayer’s appropriate composition and structure, which relies on the role of the phospholipid 
cardiolipin (CL). CL is a specific component of IMM and the most abundant in it. On the CL 
are anchored many proteins such as respiratory chain I-IV complexes and cytochrome c (cyt c) 
(Calvino Fernandez & Parra Cid, 2010). Particularly relevant is the electrostatic binding 
between CL and cyt c in the IMM since this limits the amounts of cyt c that can be released 
during apoptosis (Iverson & Orrenius, 2004; Ott et al., 2002). 
The crucial step in mitochondrion regulated apoptosis is the permeabilization of the OMM, 
often considered as the “point of no return” in apoptosis signalling (Orrenius et al., 2003), 
accompanied by the loss of mitochondrial membrane potential (ΔΨm) and mitochondrial 
transition pores (MTP) opening. OMM permeabilization is followed by the release of 
caspase activating proteins such as cyt c and second mitochondrion-derived activator of 
caspase (SMAC; also known as DIABLO) into the cytosol.  
The past 10 years have seen considerable efforts to decipher the molecular pathways leading 
to permeabilization of the OMM, and it was early recognized that the Bcl-2 family of 
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Fig. 6. Mitochondria: structure and function. A) Mitochondrial structure. B) Mitochondrial 
membranes: relationship between electron transport chain complexes, cytochrome c, and 
cardiolipin. C) Mitochondrial transition pore formation: ruptured links between protein 
complexes and cardiolipin, and release of cytochrome c into the cytosol . OMM: outer 
mitochondrial membrane; IMM: inner mitochondrial membrane; CL: cardiolipin; cyt c: 
cytochrome c; MTP: mitochondrial transition pores. 
proteins play a prominent role in the regulation and execution of this process. As a result of 
this work, three different types of Bcl-2 family proteins have been identified: (a) the pro-
apoptotic mediators, namely Bax and Bak; (b) the anti-apoptotic effectors, notably Bcl-2, Bcl-
XL and Mcl-1; and (c) a host of Bcl-2 homology domain 3 (BH3-only) proteins which control 
either both the pro- and anti-apoptotic family members or only a specific member of one 
group (Youle & Strasser, 2008). The exact mechanisms of action and interplay of all these 
proteins are still a matter of vibrant debate. But there is general agreement that Bax and Bak 
are the terminal mediators of OMM permeabilization. As a result of Bax insertion 
/oligomerization into the OMM (promoted, i.e., by the cleavage of the BH3-only protein, 
Bid), pores are formed that mediate the release of pro-apoptotic proteins from the 
intermembrane space into the cytosol. The molecular nature of such pores, that is whether 
they are proteinaceous or lipidic, is currently not known (Ott et al., 2009). 
Recently, apoptosis by mitochondrial pathway in H. pylori infection has been thoroughly 
studied (Calore et al., 2010; Calvino-Fernandez et al., 2008; Chiozzi et al., 2009; Domanska et 
al., 2010; Kim et al., 2010; Kim et al., 2007; Matsumoto et al., 2010; Yamasaki et al., 2006; 
Zhang et al., 2007). Thus, in this research line we can find papers that evidence how VacA, 
one of the major pathogenic products of H. pylori which induces large vacuoles within 
gastric epithelial cells, stimulates apoptosis via a mitochondria-dependent pathway (Chiozzi 
et al., 2009; Domanska et al., 2010; Galmiche et al., 2000; Kim et al., 2010). Some authors say 
that it interferes with mitochondrial permeability and reduces ΔΨm, followed by cyt c 
release. It is suggested that VacA may not act directly to induce cyt c release from 
mitochondria, instead Bax and Bcl-2 homologous antagonist/killer (Bak), were activated 
and relocated to mitochondria, promoting cyt c release (Calore et al., 2010; Matsumoto et al., 
2010; Yamasaki et al., 2006). 
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Not only VacA has been seen to be involved in H. pylori-induced mitochondria pathway 
apoptosis. Apurinic/apyrimidinic endonuclease-1 (APE-1) regulates transcriptional activity 
of p53, and H pylori (and ROS) induce APE-1 expression in human gastric epithelial cells, 
increasing intracellular calcium ion concentration of these cells which induces APE-1 
acetylation. This H. pylori-mediated acetylation of APE-1 suppresses Bax expression, 
preventing p53-mediated apoptosis when H. pylori infects gastric epithelial cells 
(Bhattacharyya et al., 2009; Chattopadhyay et al., 2010). 
In vivo studies indicate that H. pylori-induced apoptosis is associated with an increase in Bak 
expression in gastric biopsies from patients colonized by the bacterium. Konturek et al. 
reported induction of apoptosis with evidence of Bax up-regulation and Bcl-2 down-
regulation in duodenal ulcer patients with H. pylori infection (Konturek et al., 1999). 
It is known that mitochondria are one of the possible targets and the major intracellular 
source of free radicals (ROS), since it is estimated that 1–2% of the oxygen consumed by 
mitochondria (and they consume 85% of all body oxygen) in the electron transport chain is 
converted to O2.- (Shigenaga et al., 1994). Elevated amounts of O2.- could have detrimental 
effects on nearby molecules, modifying several proteins of the mitochondrial membrane, 
lipids or even mitochondrial DNA (which has limited protection because of its lack of 
histones). In physiological conditions, mitochondria have several enzymes (manganese-
dependent superoxide dismutase, glutathione peroxidase) and non-enzimatic systems 
(NADPH, Vit C and E) that maintain O2.- concentrations at very low levels. But when some 
events cause an overproduction of free radicals, these systems are not able to eliminate the 
excess. Therefore, overproduction of ROS may also reduce the antioxidant defenses.  
This oxidative stress may damage cellular components (Fig. 7), including polyunsaturated 
fatty acids, carbohydrates, structural and regulatory proteins, and DNA (Baik et al., 1996; 
Calvino-Fernandez et al., 2008; Jacobson, 1996). 
It could well play a role in epithelial proliferation, apoptosis, and oxidative DNA damage.  
Lipids of cellular membranes, such as CL, are particularly susceptible to oxidation due to 
the amount of double bonds in their structure, and it is expected that structural changes 
would be deleterious to normal mitochondrial function (Calvino-Fernandez et al., 2008; 
Calvino Fernandez & Parra Cid, 2010). 
It is widely known that H. pylori infection increases epithelial apoptosis in gastric mucosa, 
which may play an important role in gastric carcinogenesis (Xia & Talley, 2001), and H. 
pylori-induced apoptosis may stimulate compensatory hyperproliferation which results in 
potential preneoplastic changes in chronic H. pylori infection (Moss et al., 1996). Besides, as 
noted above, higher levels of apoptosis have been detected in ulcer lesions (Satoh et al., 
2003; Targa et al., 2007) in patients infected with bacteria, and also, this increased apoptosis 
disappears when H. pylori is eradicated. In both clinical alterations, ulcer and cancer, are also 
shown that there is an increase of oxidative stress. 
With all these data, it is reasonable to assume that whether H. pylori causes oxidative stress 
with an increase of free radicals production, these ROS could directly affect mitochondria and 
trigger the apoptosis by a similar way shown in Fig.7 (Calvino Fernandez & Parra Cid, 2010).  
An indisputable proof that these two processes (ROS and apoptosis) are related to, is the 
inhibition of apoptosis by treatment with antioxidants. In in vitro experiments (Calvino-
Fernandez et al., 2008), H. pylori caused apoptosis in gastric epithelial cells. Simultaneously 
alterations in several structural and functional characteristics of mitochondria (high O2.- 
synthesis, decreased levels of antioxidant enzymes, cardiolipin oxidation, loss of membrane 
potential, large amounts of cytosolic cit c, higher levels of Bax and caspases,...) were 
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detected. All these changes were eliminated by incubating the cells with Vit E during the 
period of infection. The antioxidant, also prevented that the cells died by apoptosis.  
 
 
Fig. 7. Morphologic and functional alterations caused by H. pylori in epithelial gastric cells. 
ROS can directly affect mitochondria and trigger apoptotic process. 
Solanum lyratum extract (SLE) was also able to suppress H. pylori-induced apoptosis (Hsu et 
al., 2010). SLE inhibited caspase-8 activation, thereby preventing the release of cyt c from 
mitochondria and activation of the subsequent downstream apoptotic pathway. Thus, SLE 
may offer a new approach for the treatment of H. pylori by down-regulation of apoptosis in 
the H. pylori infected gastric epithelium. As it does not directly target bacteria, SLE 
treatment might not cause development of resistant strains. 
5. Conclusions 
General knowledge of scientific advances is necessary not only to read and interpret the 
literature but also to diagnose and treat diseases appropriately. The biological phenomena 
contributing to oxidative stress and cell death, fundamental processes in many 
gastrointestinal diseases, are important in the science and practice of gastroenterology. 
Currently a scientific revolution is ongoing in the understanding of cell death by a process 
referred to as “apoptosis or programmed cellular death”, and the underlying causes of 
apoptosis are being the subject of many studies.  
H. pylori infection is associated with chronic gastritis, peptic ulcers, and gastric cancer. 
Extensive scientific evidence shows that in these alterations are involved oxidative stress 
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(exacerbated synthesis of ROS) caused by the bacteria by different mechanisms. In addition, 
a common feature of all these pathologies is the activation of apoptosis, either by extrinsic 
or, as it is more accepted today, for intrinsic pathway. 
Novel therapeutic strategies that may be useful in the prevention or treatment of disorders 
of the stomach and duodenum caused by bacteria, should have as target the inhibition of the 
synthesis of ROS and/or apoptosis. Whereas the excess of free radicals is the origin of these 
alterations, the first step to take would be to restore the balance between oxidants and 
antioxidant systems. This would eliminate the oxidative stress of the gastric mucosa.  
With respect to ROS, the actions may be aimed to the inhibition of its exacerbated synthesis, 
which serve to mitigate the toxic effects caused by the observed deficiencies in the 
antioxidant levels. Another strategy could be external supplementation of scavengers to 
remove this excess of free radicals. The antioxidant vitamins are the logical first choice as 
therapeutic agents, because of the large amount of data available on their role in H. pylori 
infection, gastroduodenal disease and gastric cancer.  
Other new approach for the treatment of H. pylori could be the down-regulation of apoptosis 
in infected gastric epithelium. This might be possible by administering substances that 
inhibit the activation of caspases. Thus, it would prevent the release of cyt c from 
mitochondria and as a result, the subsequent downstream apoptotic pathway.  
These actions are directed against the toxic manifestations caused by infection, while the 
traditional treatments with antibiotics have as target the bacterium itself. Consequently, 
these strategies would also prevent the development of resistant strains, an increasingly 
common problem due to the usual antibiotic treatments. 
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